LBH589 and Gemcitabine in the Treatment of Solid Tumors

This study is currently recruiting participants.
Information provided by Sarah Cannon Research Institute

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Solid Tumors
2		Interventions listed in this trial
			LBH589, Gemcitabine
3		Additional drug interventions recognized in this trial
			Gemcitabine
4		More general drug interventions related to this trial
			Anti-Infective Agents
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Antiviral Agents
			Enzyme Inhibitors
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Radiation-Sensitizing Agents
			Therapeutic Uses
5		Sponsors listed in this trial
			Sarah Cannon Research Institute
			SCRI Oncology Research Consortium
			Novartis